Table 3.
Code | R1 | R2 | Active concentrations (μM) | Survival (%) | IC50 (μM) |
---|---|---|---|---|---|
14a | H | H | 0.1, 1, 10, 100 | 86.52, 81.37, 38.25, 2.53 | 7.53 |
14b | Cl | H | 1, 10, 100 | 66.93, 33.86, 0.00 | 5.60 |
14c | OMe | H | 0.1, 1, 10, 100 | 66.20, 36.73, 1.43, 0.00 | 0.59 |
14d | H | Br | 10, 100 | 74.96, 25.87 | 55.76 |
14f | OMe | Br | 10, 100 | 70.00, 47.00 | 89.64 |
14g | H | OMe | 1, 10, 100 | 98.74, 85.76, 44.46 | 87.97 |
14h | Cl | OMe | 1, 10, 100 | 83.00, 48.00, 19.00 | 9.73 |
14i | OMe | OMe | 0.1, 1, 10, 100 | 70.16, 68.00, 29.13, 2.07 | 5.16 |
doxorubicin | 0.5 | 59.70 | 3.62* |
IC50 of doxorubicin was reported based on reference 33